In an independent study, the Angiosarcoma Project (ASCproject) in which altered genes in a cohort of 47 angiosarcomas were studied, POT1 mutations were the fourth most frequent after mutations in TP53, KDR and PIK3CA genes [54]. This evidence concerns the gene PIK3CA and angiosarcoma.